<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>CancerCompass Message Board: March 2007 follow up: Is melanoma a vitamin D deficiency cancer?</title>
    <description>CancerCompass message board discussion started by Melanomavitamindguy on 3/13/2007</description>
    <link>http://www.cancercompass.com/message-board/message/all,10317,0.htm</link>
    <pubDate>Sat, 30 Aug 2008 00:00:00 GMT</pubDate>
    <lastBuildDate>Sat, 30 Aug 2008 00:00:00 GMT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>March 2007 follow up: Is melanoma a vitamin D deficiency cancer?</title>
      <description>&amp;nbsp; TO: All melanoma researchers, doctors, and patients.&amp;nbsp;&amp;nbsp;It is high time we filled in details to sharpen the picture and eliminate any remaining doubt that melanoma is a vitamin D deficiency cancer.&amp;nbsp; The 1981 discovery (1) found that the active vitamin D metabolite 1,25D (1,25-dihydroxyvitamin D3) inhibits the growth of human melanoma cells, and although it wasn&amp;#39;t yet known for a few years (2), the skin makes this 1,25D from the circulating precursor 25D (25-hydroxyvitamin D3), which is produced in the liver from the inactive vitamin D (cholecalciferol) that is formed in skin exposed to sunlight.&amp;nbsp; Also in the mid-1980&amp;#39;s (3), it was found that the 1,25D hormone inhibits the growth of skin cells.&amp;nbsp;(See (1) Colston K, Colston MJ, Feldman D. &amp;quot;1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture.&amp;quot; Endocrinology. 1981 March;108(3):1083-6.&amp;nbsp; (2) Bikle DD, Nemanic MK, Gee E, Elias P.&amp;nbsp; &amp;quot;1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation.&amp;quot; J Clin Invest. 1986 Aug;78(2):557-66.&amp;nbsp; (3) Smith EL, Walworth NC, Holick MF. &amp;quot;Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions.&amp;quot; J Invest Dermatol. 1986 Jun;86(6):709-14.)&amp;nbsp;Now, every structure or process in the body has a logical purpose for being the way it is.&amp;nbsp; So, why would the body continue sending vitamin D (25D) to the skin if it were faced with a critical shortage?&amp;nbsp; Wouldn&amp;#39;t the epidermis be the last place the body would send that precious, remaining vitamin D (25D)?&amp;nbsp; Why would the body suffer a vitamin D (25D) deficiency first inside an organ, gland, or bone, if it didn&amp;#39;t have any chance whatsoever of gaining more vitamin D (cholecalciferol) from the internal depletion?&amp;nbsp;James SemmelAlbuquerque, New Mexico&amp;nbsp;</description>
      <author>Melanomavitamindguy</author>
      <pubDate>Tue, 13 Mar 2007 00:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>